James John Crawford
Affiliations: | Genentech, Inc., San Francisco, CA, United States |
Area:
Medicinal Chemistry; Organic Chemistry; Drug DiscoveryGoogle:
"James Crawford"Parents
Sign in to add mentorJohn A. Murphy | research assistant | 1999-1999 | University of Strathclyde |
Kenneth W. Henderson | grad student | 2001-2004 | Notre Dame |
William J. Kerr | grad student | 2001-2004 | University of Strathclyde |
K. C. Nicolaou | post-doc | 2005-2006 | Scripps Institute |
Children
Sign in to add traineeCatherine Laura Austin Salvini | grad student | ||
Mark G. McLaughlin | grad student | 2012-2012 | Genentech, Inc. |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Anderson M, Carton T, Salvini C, et al. (2024) Micelle-Promoted Reductive Amination of DNA-Conjugated Amines for DNA-Encoded Library Synthesis. Chemistry (Weinheim An Der Bergstrasse, Germany). e202400239 |
Salvini CLA, Darlot B, Davison J, et al. (2023) Fragment expansion with NUDELs - poised DNA-encoded libraries. Chemical Science. 14: 8288-8294 |
Hunter JH, Anderson MJ, Castan IFSF, et al. (2021) Highly efficient on-DNA amide couplings promoted by micelle forming surfactants for the synthesis of DNA encoded libraries. Chemical Science. 12: 9475-9484 |
Crawford JJ, Lee W, Johnson AR, et al. (2020) Stereochemical Differences in Fluorocyclopropyl Amides Enable Tuning of Btk Inhibition and Off-Target Activity. Acs Medicinal Chemistry Letters. 11: 1588-1597 |
Zhang C, Crawford JJ, Landry ML, et al. (2020) Strategies to Mitigate the Bioactivation of Aryl Amines. Chemical Research in Toxicology |
Landry ML, Crawford JJ. (2020) Log Contributions of Substituents Commonly Used in Medicinal Chemistry. Acs Medicinal Chemistry Letters. 11: 72-76 |
Crawford JJ, Liao D, Kolesnikov A, et al. (2020) Synthesis of an Azabicyclo[3.1.0]hexanone-Containing Inhibitor of NF-κΒ Inducing Kinase via Catalytic C–H Activation Synthesis |
Bronner SM, Merrick KA, Murray J, et al. (2019) Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma. Bioorganic & Medicinal Chemistry Letters |
Crawford JJ, Bronner SM, Zbieg JR. (2018) Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review. Expert Opinion On Therapeutic Patents |
Blaquiere N, Castanedo G, Burch J, et al. (2018) A scaffold-hopping approach to discover potent, selective and efficacious inhibitors of NF-κB inducing kinase. Journal of Medicinal Chemistry |